TGTX Tg Therapeutics PE ratio, current and historical analysis
As of Mar 12, 2025, the Tg Therapeutics stock's price-to-earnings ratio is 232.69. This results from the current EPS of $0.16 and stock price of $37.23.
TGTX PE ratio history
Tg Therapeutics PE ratio by year
Maximum annual decrease: -0.87% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 188.13 | -0.87% | $30.1 | $0.16 |
| 2023 | 189.78 | N/A | $17.08 | $0.09 |
| 2022 | N/A | N/A | $11.83 | -$1.65 |
| 2021 | N/A | N/A | $19 | -$2.63 |
| 2020 | N/A | N/A | $52.02 | -$2.42 |
| 2019 | N/A | N/A | $11.1 | -$1.96 |
| 2018 | N/A | N/A | $4.1 | -$2.3 |
| 2017 | N/A | N/A | $8.2 | -$1.91 |
| 2016 | N/A | N/A | $4.65 | -$1.6 |
| 2015 | N/A | N/A | $11.93 | -$1.38 |
| 2014 | N/A | N/A | $15.84 | -$1.64 |
| 2013 | N/A | N/A | $3.9 | -$0.81 |
| 2012 | N/A | N/A | $3.64 | -$1.38 |
| 2011 | N/A | N/A | $1.13 | -$0.44 |
| 2010 | 6.66 | N/A | $112.5 | $16.88 |
Tg Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 188.13 | N/A | $30.1 | $0.16 |
| Sep 2024 | N/A | N/A | $23.39 | -$0.09 |
| Jun 2024 | 26.16 | -50.12% | $17.79 | $0.68 |
| Mar 2024 | 52.45 | -72.36% | $15.21 | $0.29 |
| Dec 2023 | 189.78 | N/A | $17.08 | $0.09 |
| Sep 2023 | N/A | N/A | $8.36 | -$0.39 |
| Jun 2023 | N/A | N/A | $24.84 | -$1.45 |
| Mar 2023 | N/A | N/A | $15.04 | -$1.41 |
| Dec 2022 | N/A | N/A | $11.83 | -$1.65 |
| Sep 2022 | N/A | N/A | $5.92 | -$1.77 |
| Jun 2022 | N/A | N/A | $4.25 | -$2.16 |
| Mar 2022 | N/A | N/A | $9.51 | -$2.45 |
| Dec 2021 | N/A | N/A | $19 | -$2.63 |
| Sep 2021 | N/A | N/A | $33.28 | -$2.65 |
| Jun 2021 | N/A | N/A | $38.79 | -$2.73 |
TGTX average PE ratio chart
TGTX PE vs peers
TGTX's PE ratio stands higher than its peer stocks ALKS and NERV.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NERV Minerva Neurosciences Inc | 9.16 | $12.17M |
| ALKS Alkermes plc | 15.06 | $5.44B |
| TGTX Tg Therapeutics Inc | 232 | $5.83B |
Frequently asked questions
What is Tg Therapeutics's PE ratio?
The price to earnings ratio for TGTX stock as of Mar 12, 2025, stands at 232.69.
Why is Tg Therapeutics's PE ratio so high?
TGTX's stock price is trading at a higher multiple of earnings, which is why its PE ratio of 232.69 is considered high.
How is TGTX's PE ratio calculated (Tg Therapeutics PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Mar 12, 2025), Tg Therapeutics's stock price is $37.23. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.16. Therefore, Tg Therapeutics's PE ratio for today is 232.69. PE RATIO(232.69) = STOCK PRICE($37.23) / TTM EPS($0.16)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.